seed
Stage
1
Investors
About
Red Arrow Therapeutics develops nanopolymer drug-delivery technology for targeted cancer therapies using programmable encapsulation to reduce toxicity and improve on-target tumor delivery.
Explore Red Arrow Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.